Found: 83
Select item for more details and to access through your institution.
Changes in mortality due to Chronic Liver Diseases (CLD) during the COVID-19 pandemic: Data from the United States' National Vital Statistics System.
- Published in:
- PLoS ONE, 2024, v. 19, n. 9, p. 1, doi. 10.1371/journal.pone.0289202
- By:
- Publication type:
- Article
Disclosure of Medical Errors: Ethical Considerations for the Development of a Facility Policy and Organizational Culture Change.
- Published in:
- Policy, Politics & Nursing Practice, 2005, v. 6, n. 2, p. 127, doi. 10.1177/1527154404272611
- By:
- Publication type:
- Article
Body size, energy reserves, and competitive ability in three speciesof Cladocera
- Published in:
- Ecology, 1982, v. 63, n. 6, p. 1780
- By:
- Publication type:
- Article
Economic and Quality-of-Life Implications of Non-Alcoholic Fatty Liver Disease.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Correction: Economic and clinical burden of viral hepatitis in California: A population-based study with longitudinal analysis.
- Published in:
- PLoS ONE, 2018, v. 13, n. 12, p. 1, doi. 10.1371/journal.pone.0209715
- By:
- Publication type:
- Article
Economic and clinical burden of viral hepatitis in California: A population-based study with longitudinal analysis.
- Published in:
- PLoS ONE, 2018, v. 13, n. 5, p. 1, doi. 10.1371/journal.pone.0196452
- By:
- Publication type:
- Article
Reply to Bailly et al.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate Coronavirus Disease 2019 (COVID-19): A Real-World Experience.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 6, p. 1063, doi. 10.1093/cid/ciab579
- By:
- Publication type:
- Article
Hepatitis C in Patients With Minimal or No Hepatic Fibrosis: The Impact of Treatment and Sustained Virologic Response on Patient-Reported Outcomes.
- Published in:
- Clinical Infectious Diseases, 2018, v. 66, n. 11, p. 1742, doi. 10.1093/cid/cix1106
- By:
- Publication type:
- Article
Development and Validation of a Risk Score for Liver Cirrhosis Prediction in Untreated and Treated Chronic Hepatitis B.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Outcomes of hospitalized patients with COVID-19 during the course of the pandemic in a fully integrated health system.
- Published in:
- PLoS ONE, 2022, v. 18, n. 2, p. 1, doi. 10.1371/journal.pone.0263417
- By:
- Publication type:
- Article
Ribavirin-Free RegimenWith Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical Trials.
- Published in:
- Clinical Infectious Diseases, 2016, v. 63, n. 8, p. 1042, doi. 10.1093/cid/ciw496
- By:
- Publication type:
- Article
1850-P: High Prevalence of Fatigue and Pruritus in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis (NASH): The Impact on Patient-Reported Outcomes (PROs).
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1850-P
- By:
- Publication type:
- Article
1449-P: The Enhanced Liver Fibrosis (ELF) Score Predicts Adverse Clinical and Patient-Reported Outcomes in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis (NASH).
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1449-P
- By:
- Publication type:
- Article
1448-P: Enhanced Liver Fibrosis (ELF) Test Can Accurately Predict Advanced Fibrosis in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease (NAFLD).
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1448-P
- By:
- Publication type:
- Article
Trends in anemia care in non-dialysis-dependent chronic kidney disease (CKD) patients in the United States (2006-2015).
- Published in:
- 2018
- By:
- Publication type:
- journal article
The impact of variants and vaccination on the mortality and resource utilization of hospitalized patients with COVID-19.
- Published in:
- BMC Infectious Diseases, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12879-022-07657-z
- By:
- Publication type:
- Article
Global treatment rate and barriers to direct‐acting antiviral therapy: A systematic review and meta‐analysis of 146 studies and 1 760 352 hepatitis C virus patients.
- Published in:
- Liver International, 2023, v. 43, n. 6, p. 1195, doi. 10.1111/liv.15550
- By:
- Publication type:
- Article
The impact of fatigue on mortality of patients with non‐alcoholic fatty liver disease: Data from National Health and nutrition examination survey 2005–2010 and 2017–2018.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2646, doi. 10.1111/liv.15437
- By:
- Publication type:
- Article
Response to: Comparison of MAFLD and NAFLD diagnostic criteria in real world.
- Published in:
- Liver International, 2020, v. 40, n. 12, p. 3145, doi. 10.1111/liv.14664
- By:
- Publication type:
- Article
Fatty liver is not independently associated with the rates of complete response to oral antiviral therapy in chronic hepatitis B patients.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1052, doi. 10.1111/liv.14415
- By:
- Publication type:
- Article
Hepatitis B and renal function: A matched study comparing non‐hepatitis B, untreated, treated and cirrhotic hepatitis patients.
- Published in:
- Liver International, 2019, v. 39, n. 4, p. 655, doi. 10.1111/liv.14009
- By:
- Publication type:
- Article
Response to the letter: Hepatitis C screening in opioid epidemics in the United States and societal perspectives.
- Published in:
- Liver International, 2018, v. 38, n. 7, p. 1331, doi. 10.1111/liv.13891
- By:
- Publication type:
- Article
In an era of highly effective treatment, hepatitis C screening of the United States general population should be considered.
- Published in:
- Liver International, 2018, v. 38, n. 2, p. 258, doi. 10.1111/liv.13519
- By:
- Publication type:
- Article
A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ- NAFLD.
- Published in:
- Liver International, 2017, v. 37, n. 8, p. 1209, doi. 10.1111/liv.13391
- By:
- Publication type:
- Article
Presumed Nonalcoholic Fatty Liver Disease Among Medicare Beneficiaries With HIV, 2006–2016.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 1, p. N.PAG, doi. 10.1093/ofid/ofz509
- By:
- Publication type:
- Article
Starvation in Daphnia: Energy reserves and reproductive allocation.
- Published in:
- Limnology & Oceanography, 1983, v. 28, n. 4, p. 667, doi. 10.4319/lo.1983.28.4.0667
- By:
- Publication type:
- Article
Tobacco Use Triggers for Mothers of Infants: Implications For Pediatric Nursing Practice.
- Published in:
- Pediatric Nursing, 2008, v. 34, n. 3, p. 253
- By:
- Publication type:
- Article
Proton pump inhibitors and risk of liver cancer and mortality in patients with chronic liver disease: a systematic review and meta-analysis.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 6, p. 851, doi. 10.1007/s00228-020-02854-8
- By:
- Publication type:
- Article
Confirmatory factor analysis of the Minnesota living with heart failure questionnaire among patients following open heart surgery for valve dysfunction.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Increasing co-morbidities in chronic hepatitis B patients: experience in primary care and referral practices during 2000-2015.
- Published in:
- Clinical & Translational Gastroenterology, 2018, v. 9, n. 3, p. 1, doi. 10.1038/s41424-018-0007-6
- By:
- Publication type:
- Article
Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health‐related quality of life in East Asian patients with hepatitis C virus infection.
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 12, p. 1429, doi. 10.1111/jvh.12965
- By:
- Publication type:
- Article
The comprehensive outcomes of hepatitis C virus infection: A multi‐faceted chronic disease.
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 3, p. 6, doi. 10.1111/jvh.13005
- By:
- Publication type:
- Article
Editorial: Revisit the causes and long‐term outcomes in cirrhosis patients—Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Updates in characteristics and survival rates of cirrhosis in a nationwide cohort of real‐world U.S. patients, 2003–2021.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 2, p. 212, doi. 10.1111/apt.18024
- By:
- Publication type:
- Article
Treatment rates and factors associated with direct‐acting antiviral therapy for insured patients with hepatitis C‐related hepatocellular carcinoma – A real‐world nationwide study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 3, p. 350, doi. 10.1111/apt.17794
- By:
- Publication type:
- Article
The combination of the enhanced liver fibrosis and FIB‐4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 12, p. 1417, doi. 10.1111/apt.17472
- By:
- Publication type:
- Article
Letter: should we abandon FIB‐4 to characterise noninvasively patients with NAFLD? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 8, p. 922, doi. 10.1111/apt.17448
- By:
- Publication type:
- Article
Editorial: let's get physical—long‐term benefits of vigorous physical activity in patients with nonalcoholic fatty liver disease. Authors' reply.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Vigorous physical activity provides protection against all‐cause deaths among adults patients with nonalcoholic fatty liver disease (NAFLD).
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 6, p. 709, doi. 10.1111/apt.17308
- By:
- Publication type:
- Article
A practical use of noninvasive tests in clinical practice to identify high‐risk patients with nonalcoholic steatohepatitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 3, p. 304, doi. 10.1111/apt.17346
- By:
- Publication type:
- Article
Impact of advanced practice providers on characteristics and quality of care of patients with chronic hepatitis B.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 11/12, p. 1591, doi. 10.1111/apt.17254
- By:
- Publication type:
- Article
Review article: the epidemiologic burden of non‐alcoholic fatty liver disease across the world.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 6, p. 942, doi. 10.1111/apt.17158
- By:
- Publication type:
- Article
Meta‐analysis: global prevalence, trend and forecasting of non‐alcoholic fatty liver disease in children and adolescents, 2000–2021.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 3, p. 396, doi. 10.1111/apt.17096
- By:
- Publication type:
- Article
Editorial: a diabetologist's perspective on the diagnosis and monitoring of NAFLD—Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 4, p. 712, doi. 10.1111/apt.15929
- By:
- Publication type:
- Article
Clinical assessment for high‐risk patients with non‐alcoholic fatty liver disease in primary care and diabetology practices.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 3, p. 513, doi. 10.1111/apt.15830
- By:
- Publication type:
- Article
The impact of modifiable risk factors on the long‐term outcomes of non‐alcoholic fatty liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 2, p. 291, doi. 10.1111/apt.15580
- By:
- Publication type:
- Article
Systematic review with meta‐analysis: extrahepatic manifestations in chronic hepatitis C virus‐infected patients in East Asia.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2019, v. 49, n. 6, p. 644, doi. 10.1111/apt.15131
- By:
- Publication type:
- Article
How long is too long: A retrospective study evaluating the impact of the duration of noninvasive oxygenation support strategies (high flow nasal cannula & BiPAP) on mortality in invasive mechanically ventilated patients with COVID-19.
- Published in:
- PLoS ONE, 2023, v. 17, n. 2, p. 1, doi. 10.1371/journal.pone.0281859
- By:
- Publication type:
- Article
Understanding the Burden of Nonalcoholic Fatty Liver Disease: Time for Action.
- Published in:
- Diabetes Spectrum, 2024, v. 37, n. 1, p. 9, doi. 10.2337/dsi23-0010
- By:
- Publication type:
- Article